Clinical trial

Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC

NCT05060796

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cells Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC

Design: INTERVENTIONAL · Status: RECRUITING · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2019-09-01

PhaseEARLY_PHASE1

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cellsBIOLOGICAL

Sponsors & collaborators

Second Affiliated Hospital of Guangzhou Medical Universitylead sponsor

Mapped research locations

GuangzhouChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05060796 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.